J2513 — Injection, pentastarch, 10% solution, 100 ml
J2513 is a HCPCS Level II code for injection, pentastarch, 10% solution, 100 ml. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J2513 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J2513
- Long descriptor
- Injection, pentastarch, 10% solution, 100 ml
- Short descriptor
- Pentastarch 10% solution
- Added
- January 1, 2006
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J2513
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2513 is not quite right, the correct code is very often within a few positions of it.
- J2502Injection, pasireotide long acting, 1 mg
- J2503Injection, pegaptanib sodium, 0.3 mgterminated
- J2504Injection, pegademase bovine, 25 iuterminated
- J2505Injection, pegfilgrastim, 6 mgterminated
- J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2507Injection, pegloticase, 1 mg
- J2508Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2515Injection, pentobarbital sodium, per 50 mg
- J2516Injection, pentamidine isethionate, 1 mg
- J2540Injection, penicillin g potassium, up to 600,000 units
- J2543Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
- J2545Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
- J2547Injection, peramivir, 1 mg
- J2550Injection, promethazine hcl, up to 50 mg
- J2560Injection, phenobarbital sodium, up to 120 mg
Questions about J2513
What is HCPCS code J2513?
J2513 is a HCPCS Level II code for injection, pentastarch, 10% solution, 100 ml. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2513?
The CMS HCPCS file marks J2513 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J2513 still valid?
No. J2513 was terminated on December 31, 2025 and should not be used on new claims.